MuSK-CAART

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
11	重症筋無力症	1

11. 重症筋無力症

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05451212 (ClinicalTrials.gov)	November 23, 2022	30/6/2022	Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAARTfor MuSK Myasthenia ...	A Phase 1, Open-label, Safety and Dose-finding Study of Autologous Muscle-specific Tyrosine Kinase C ...	MuSK Myasthenia Gravis	Biological: MuSK-CAART	Cabaletta Bio	NULL	Recruiting	18 Years	N/A	All	24	Phase 1	United States

First Previous1Next Last